Skip to main content
. 2023 May 25;16:89. doi: 10.1186/s13104-023-06358-3

Table 2.

Quality of Life (QoL) of Brain Tumor Patients as measured by the EORCT QLQ-C30 and QL-BN20

QLQ-C30 Component Mean (SD)
Global QoL 75.73 (14.9)
Functional scale
 Physical functioning 81.65(21.45)
 Role functioning 81.20 (33.02)
 Emotional functioning 86.07 (13.34)
 Cognitive functional 84.53 (20.39)
 Social functional 87.93 (21.01)
Symptom scales
 Fatigue 9.55 (11.95)
 Nausea 9.20 (15.00)
 Pain 29.70 (30.48)
 Dyspnea 4.66 (14.02)
 Insomnia 25.06 (25.40)
 Appetite loss 26.13 (26.40)
 Constipation 2.13 (9.20)
 Diarrhea 11.46 (22.59)
 Financial difficulties 21.06 (32.59)
QLQ-BN20 component Mean (SD)
Symptom scale
 Future uncertainty 7.53 (14.32)
 Visual disorder 8.16 (15.30)
 Motor symptoms 11.46 (17.15)
 Communication deficit 9.33 (16.38)
 Headache 21.46 (25.46)
 Seizures 2.93 (11.96)
 Drowsiness 10.13 (21.00)
 Hair loss 10.53 (21.12)
 Itchy skin 7.33 (17.27)
 Weakness 18.40 (25.33)
 Bladder control 5.86 (17.45)